查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571822

美国胃肠病门诊手术中心市场规模、份额和趋势分析报告：按所有权和细分市场预测，2024-2030 年

U.S. Gastroenterology Ambulatory Surgery Centers Market Size, Share & Trends Analysis Report By Ownership (Hospital-affiliated, Freestanding, Corporation-owned), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

美国胃肠病门诊手术中心市场成长与趋势

Grand View Research 的最新报告显示，到 2030 年，美国胃肠病门诊手术中心市场规模预计将达到 97.8 亿美元。

预计2024年至2030年复合年增长率为6.8%。这种增长得益于门诊手术中心提供的成本效率、患者治疗效果的改善以及患者的便利性。此外，消化器官系统疾病盛行率上升和老年人口不断增加等因素预计将支持成长。

建立和维护医院及其他医疗保健设施是资本集中的。此外，由于住院费用较高，越来越多的患者更喜欢门诊设施而不是门诊就诊。近年来，美国门诊手术中心（ASC）的数量迅速增加，以满足对替代手术设施不断增长的需求。目前美国有超过 9,280 个 ASC，集中在加利福尼亚州、佛罗里达州和德克萨斯。

其他细分市场包括由医师-医院、医师-医院-企业和医师-企业-胃肠病学等各种合资企业拥有的ASC。由于更好的患者治疗效果、更高的生产力和所有权关係，联合资助的医生-医院 ASC 越来越受欢迎。

联盟和收购的增加是预计推动市场成长的主要因素。 2019 年 2 月，SurgCenter Development 与外科合作伙伴达成协议，开发一个新的门诊手术中心。

服务供应商的主要产业参与者包括Envision Healthcare Corporation、Tenet Healthcare Corporation、Surgery Partners、Community Health Systems, Inc. (CHS)、Universal Health Service (UHS)、Hospital Corporation of America (HCA) 和Surgery Care Affiliates (SCA )。

美国胃肠病门诊手术中心市场报告亮点：

  • 由于对临床环境的最大程度的专业控制、高盈利以及为患者提供的护理质量，独立拥有的细分市场在 2023 年占据了最高的市场占有率。
  • 市场成长的推动因素是政府高支出开拓门诊手术中心以降低治疗成本并提高可及性，以及改善在 ASC 进行的手术的报销政策。
  • 预计未来几年企业所有权将以 5.4% 的复合年增长率成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国胃肠病门诊手术中心市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国胃肠病门诊手术中心市场分析工具
    • 波特的分析
    • PESTEL分析

第四章美国胃肠病门诊手术中心市场：所有权估计和趋势分析

  • 细分仪表板
  • 美国胃肠病门诊手术中心市场：2023 年和 2030 年所有权变更分析
  • 医院相关
  • 自主型
  • 企业所有权
  • 其他的

第五章竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • TH Medical.
    • GE Healthcare
    • Universal Health Services, Inc.
    • Covenant Physician Partners
    • Regent Surgery
    • Cardinal Health.
    • Boston Scientific Corporation
    • Olympus Corporation
    • Koninklijke Philips NV
    • Cook Medical
简介目录
Product Code: GVR-3-68038-928-9

U.S. Gastroenterology Ambulatory Surgery Centers Market Growth & Trends:

The U.S. gastroenterology ambulatory surgery center market size is anticipated to reach USD 9.78 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2024 to 2030. The growth can be attributed to cost-efficiency, improved patient outcomes, and patient convenience provided by the ambulatory surgery centers. In addition, factors such as rising prevalence of digestive diseases and growing geriatric population are expected to fuel the growth.

Establishment and maintenance of hospitals and other healthcare settings are capital-intensive. In addition, high cost of hospitalization associated with inpatient admission has led to increased patient preference for outpatient facilities over hospital visits. The number of ambulatory surgery centers (ASCs) in U.S. has witnessed a surge in the last few years in order to fulfill the growing demand for alternate surgical facilities. Currently, there are more than 9,280 ASCs in U.S. with highest concentration in California, Florida, and Texas.

The other segment includes ASCs owned by various joint ventures such as physician-hospital, physician-hospital-corporate, and physician-corporate gastroenterology. The physician-hospital joint-venture ASCs are gaining traction due to better patient outcomes, enhanced productivity, and ownership interest.

The rising number of partnerships and acquisitions is a key factor expected to drive the growth of the market. In February 2019, SurgCenter Development entered into an agreement with Surgery Partners to develop new ambulatory surgery centers.

Key industry participants among the service provider include Envision Healthcare Corporation; Tenet Healthcare Corporation; Surgery Partners; Community Health Systems, Inc. (CHS); Universal Health Service (UHS); Hospital Corporation of America (HCA); Surgery Care Affiliates (SCA); SurgCenter Development; Covenant Surgical Partners; and Regent Surgical Health.

U.S. Gastroenterology Ambulatory Surgery Centers Market Report Highlights:

  • The freestanding ownership segment accounted for the highest market share in 2023 owing to maximum professional control over clinical environment, high profitability, and quality of care delivered to patients.
  • High government expenditure for the development of ambulatory surgery centers to reduce treatment costs and increase accessibility along with better reimbursement policies for procedures performed at ASC are driving the market growth.
  • Corporation-owned ownership is expected to grow at a CAGR of 5.4% over the projected years.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Gastroenterology Ambulatory Surgery Centers Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Gastroenterology Ambulatory Surgery Centers Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Hospital-affiliated
    • 4.3.1. Hospital-affiliated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Freestanding
    • 4.4.1. Freestanding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Corporation-owned
    • 4.5.1. Corporation-owned Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis by Key Market Participants
  • 5.2. Company Categorization
  • 5.3. Company Heat Map Analysis
  • 5.4. Company Profiles
    • 5.4.1. TH Medical.
      • 5.4.1.1. Participant's Overview
      • 5.4.1.2. Financial Performance
      • 5.4.1.3. Product Benchmarking
      • 5.4.1.4. Recent Developments/ Strategic Initiatives
    • 5.4.2. GE Healthcare
      • 5.4.2.1. Participant's Overview
      • 5.4.2.2. Financial Performance
      • 5.4.2.3. Product Benchmarking
      • 5.4.2.4. Recent Developments/ Strategic Initiatives
    • 5.4.3. Universal Health Services, Inc.
      • 5.4.3.1. Participant's Overview
      • 5.4.3.2. Financial Performance
      • 5.4.3.3. Product Benchmarking
      • 5.4.3.4. Recent Developments/ Strategic Initiatives
    • 5.4.4. Covenant Physician Partners
      • 5.4.4.1. Participant's Overview
      • 5.4.4.2. Financial Performance
      • 5.4.4.3. Product Benchmarking
      • 5.4.4.4. Recent Developments/ Strategic Initiatives
    • 5.4.5. Regent Surgery
      • 5.4.5.1. Participant's Overview
      • 5.4.5.2. Financial Performance
      • 5.4.5.3. Product Benchmarking
      • 5.4.5.4. Recent Developments/ Strategic Initiatives
    • 5.4.6. Cardinal Health.
      • 5.4.6.1. Participant's Overview
      • 5.4.6.2. Financial Performance
      • 5.4.6.3. Product Benchmarking
      • 5.4.6.4. Recent Developments/ Strategic Initiatives
    • 5.4.7. Boston Scientific Corporation
      • 5.4.7.1. Participant's Overview
      • 5.4.7.2. Financial Performance
      • 5.4.7.3. Product Benchmarking
      • 5.4.7.4. Recent Developments/ Strategic Initiatives
    • 5.4.8. Olympus Corporation
      • 5.4.8.1. Participant's Overview
      • 5.4.8.2. Financial Performance
      • 5.4.8.3. Product Benchmarking
      • 5.4.8.4. Recent Developments/ Strategic Initiatives
    • 5.4.9. Koninklijke Philips NV
      • 5.4.9.1. Participant's Overview
      • 5.4.9.2. Financial Performance
      • 5.4.9.3. Product Benchmarking
      • 5.4.9.4. Recent Developments/ Strategic Initiatives
    • 5.4.10. Cook Medical
      • 5.4.10.1. Participant's Overview
      • 5.4.10.2. Financial Performance
      • 5.4.10.3. Product Benchmarking
      • 5.4.10.4. Recent Developments/ Strategic Initiatives